Morning Movers 6/21: EFJI, AIPC, GKK, RADA, BVF Higher; AFFY, ZIOP, UAHC, CYPB, CPKI Lower
Affymax, Inc. (Nasdaq: AFFY) 65.5% LOWER; Affymax and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematideā¢/peginesatide, for the treatment of anemia in chronic...
Get Alerted When News Hits On This Stock - FREE!

